Completed
Neoadjuvant Anti-PD1 in HCC
NCT05471674
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Queen Mary Hospital Hong Kong
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,856 public trials
2,106 recruiting studies
Carcinoma trial results
NCT04764643
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Xijing Hospital of Digestive Disease Xi'an, Shaanxi, China
Completed
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
NCT03775213
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
- Locations
-
- Duke Mammography Clinic Durham, North Carolina, United States
NCT02438436
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Nanning, Guangxi, China
NCT02420821
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of California at Irvine Medical Center; Department of Oncology Orange, California, United States
- University of California San Francisco, California, United States
- University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States
Completed
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
NCT02120807
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering West Harrison Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT04072224
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +20 more
- Locations
-
- CHU de Nîmes Nîmes, France
Completed
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
NCT01607905
- Conditions
- Adenocarcinoma, Astrocytoma, Carcinoma, +28 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Gabrail Cancer Center Canton, Ohio, United States
NCT03766035
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +9 more
- Locations
-
- Sutter Davis Hospital Davis, California, United States
- UC Davis Health Sacramento, California, United States
- University of Utah Hospital and Clinic Salt Lake City, Utah, United States
- Aspen Woods Clinic Calgary, Alberta, Canada
NCT03999684
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States